Cidara Therapeutics (CDTX)
(Delayed Data from NSDQ)
$12.63 USD
-0.37 (-2.85%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $12.59 -0.04 (-0.32%) 6:00 PM ET
1-Strong Buy of 5 1
C Value A Growth C Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -1.40 |
EPS Last Quarter | -0.80 |
Last EPS Surprise | NA |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -13.00 |
Next Year | 12.63 |
EPS (TTM) | -4.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 14.50M | 3.30M | 27.91M | 107.17M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 14.50M | 3.30M | 27.91M | 107.17M |
Low Estimate | 14.50M | 3.30M | 27.91M | 107.17M |
Year ago Sales | 25.99M | 7.61M | 63.90M | 27.91M |
Year over Year Growth Est. | -44.21% | -56.64% | -56.33% | 283.98% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.40 | -4.00 | -13.00 | 12.63 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -1.40 | -4.00 | -13.00 | 12.60 |
High Estimate | -1.40 | -4.00 | -13.00 | 12.63 |
Low Estimate | -1.40 | -4.00 | -13.00 | 12.63 |
Year ago EPS | 0.60 | -2.80 | -5.20 | -13.00 |
Year over Year Growth Est. | -333.33% | -42.86% | -150.00% | 197.15% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.40 | -4.00 | -13.00 | 12.63 |
7 Days Ago | -1.40 | -4.00 | -13.00 | 12.60 |
30 Days Ago | -1.40 | -4.00 | -13.00 | 12.60 |
60 Days Ago | -1.40 | -4.00 | -13.00 | 12.60 |
90 Days Ago | -1.40 | -4.00 | -13.00 | 12.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.40 | -4.00 | -13.00 | 12.63 |
Zacks Consensus Estimate | -1.40 | -4.00 | -13.00 | 12.63 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.80 | -1.80 | -2.80 | 0.60 | NA |
Estimate | NA | -2.80 | -1.60 | 1.20 | NA |
Difference | NA | 1.00 | -1.20 | -0.60 | -0.27 |
Surprise | NA | 35.71% | -75.00% | -50.00% | -29.76% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more